CHEMORADIOTHERAPY WITH 5-FU VERSUS CAPECITABINE ON RECTAL CANCER DOWNSTAGING

被引：0
|
作者：
Aguas, L. [1 ]
Salgado, M. [1 ]
Davila, C. [1 ]
Costa, A. S. [1 ]
Almeida, D. [1 ]
Barbosa, M. [1 ]
Caeiro, C. [1 ]
Sarmento, C. [1 ]
Marques, M. [1 ]
Damasceno, M. [1 ]
机构：
[1] Hosp Sao Joao, Oporto, Portugal
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [1] Efficacy of capecitabine vs. infusional 5-FU as neoadjuvant chemoradiotherapy for rectal cancer
    Kocakova, I
    Kubala, E.
    Spurny, V
    Dvorak, J.
    Finek, J.
    Cwiertka, K.
    Prausova, J.
    Hoch, J.
    Vyzula, R.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 66 - 66
  • [2] Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer
    Kim, JS
    Kim, JS
    Cho, MJ
    Yoon, WH
    Song, KS
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2006, 21 (01) : 52 - 57
  • [3] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [4] Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer
    Dolinsky, CM
    Mahmoud, NN
    Mick, R
    Sun, W
    Whittington, RW
    Solin, LJ
    Haller, DG
    Fry, RD
    Metz, JM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S277 - S277
  • [5] Neoadjuvant chemoradiation with capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: A matched pair analysis
    Das, P
    Lin, EH
    Bhatia, S
    Skibber, JM
    Rodriguez-Bigas, MA
    Feig, BW
    Hoff, PM
    Eng, C
    Wolff, RA
    Krishnan, S
    Janjan, NA
    Crane, CH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S164 - S164
  • [6] Cost analysis of capecitabine versus 5-FU/LV for colorectal cancer patients in the Netherlands
    Postma, MJ
    van Hartskamp, D
    Jansman, FG
    Willemse, PH
    Brouwers, JR
    [J]. VALUE IN HEALTH, 2002, 5 (06) : 540 - 540
  • [7] Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer
    Yu, Irene S.
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] A comparison of capecitabine versus infusional 5-FU used concurrently with preoperative radiation for rectal cancer: A population-based study
    Lim, H. J.
    Gill, S.
    Hay, J.
    Savage, K. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
    M. W. Saif
    Shahrukh Hashmi
    Daniel Zelterman
    Khaldoun Almhanna
    Richard Kim
    [J]. International Journal of Colorectal Disease, 2008, 23
  • [10] Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
    Saif, M. W.
    Hashmi, Shahrukh
    Zelterman, Daniel
    Almhanna, Khaldoun
    Kim, Richard
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (02) : 139 - 145
12345